- Home
- DTST vs KALA Comparison
DTST vs KALA Comparison
Compare DTST & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- KALA
- Stock Information
- Founded
- DTST 2001
- KALA 2009
- Country
- DTST United States
- KALA United States
- Employees
- DTST N/A
- KALA N/A
- Industry
- DTST EDP Services
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- KALA Health Care
- Exchange
- DTST Nasdaq
- KALA Nasdaq
- Market Cap
- DTST 28.3M
- KALA 27.3M
- IPO Year
- DTST N/A
- KALA 2017
- Fundamental
- Price
- DTST $4.88
- KALA $7.93
- Analyst Decision
- DTST
- KALA Strong Buy
- Analyst Count
- DTST 0
- KALA 2
- Target Price
- DTST N/A
- KALA $15.00
- AVG Volume (30 Days)
- DTST 71.8K
- KALA 39.3K
- Earning Date
- DTST 11-14-2024
- KALA 11-12-2024
- Dividend Yield
- DTST N/A
- KALA N/A
- EPS Growth
- DTST N/A
- KALA N/A
- EPS
- DTST 0.02
- KALA N/A
- Revenue
- DTST $25,143,911.00
- KALA N/A
- Revenue This Year
- DTST $2.57
- KALA N/A
- Revenue Next Year
- DTST $11.16
- KALA N/A
- P/E Ratio
- DTST $242.41
- KALA N/A
- Revenue Growth
- DTST 1.64
- KALA N/A
- 52 Week Low
- DTST $2.76
- KALA $4.21
- 52 Week High
- DTST $8.00
- KALA $9.25
- Technical
- Relative Strength Index (RSI)
- DTST 61.46
- KALA 70.65
- Support Level
- DTST $3.98
- KALA $6.52
- Resistance Level
- DTST $4.34
- KALA $8.79
- Average True Range (ATR)
- DTST 0.32
- KALA 0.47
- MACD
- DTST 0.02
- KALA 0.19
- Stochastic Oscillator
- DTST 91.84
- KALA 72.44
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.